February 27, 2024

Boston-based gene therapy client cleared their first IND in rare disease indication.

A Boston-based gene therapy client just cleared their first IND in a rare disease indication; our cross-functional team provides support in data management, clinical quality assurance, medical writing, and QC.  This is a major milestone for both the organization and the gene editing field.

BioBridges provides clinical development services to emerging and established pharmaceutical, biotechnology and medical device companies. Since our inception in 2005, we have designed and built our proprietary and scalable Career Portfolio® Management model, which engages our professionals to meet the specialized needs of our clients’ clinical programs. This model has stood the test of time in our work with over 500 companies since our founding in Cambridge, MA. Today, we serve a national base of clients around the U.S. with our highly skilled professionals as we collaborate with our clients to advance science and produce therapies for patients who need them.

Service Areas

Clinical experts can help you bridge the gap between your life's work and a healthier world.

Learn More